Live news related to PHARMING GROUP stock (NL0010391025): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Pharming Group N.V. unveiled on Tuesday its financial outlook for 2026 during an investor day, announcing expected revenues between $405 and $425 mill…
Pharming Group announced on Monday that the U.S. Food and Drug Administration issued a Complete Response Letter regarding its supplemental marketing a…
Pharming Group shares closed Thursday, January 22, at 1.69 euros, marking a remarkable surge of 11.33% from the previous day. This spike occurred as t…
This Thursday morning, the biopharmaceutical stock Pharming Group is gaining ground on the Paris Stock Exchange, building on a positive momentum that …
Pharming Group's stock marked a significant increase of 4.69% at midday on Thursday, January 8, reaching 1.54 euros, driven by the release of prelimin…
The Dutch laboratory Pharming Group has released its unaudited preliminary results for the fiscal year 2025, reporting a revenue of approximately $376…
Pharming Group N.V. has announced its participation in the Oppenheimer Movers in Rare Disease Summit to be held in New York on December 11, 2025.
Pharming Group N.V. has announced its participation in the Oppenheimer Movers in Rare Disease Summit scheduled for December 11, 2025, in New York.
Pharming Group's stock has marked a significant increase of 4.16% this Monday, November 24, trading at 1.4760 euros compared to 1.42 euros the previou…
At midday this Thursday, November 20, Pharming Group's stock is up by 4.82% at 1.456 euros, having closed the previous day at 1.39 euros. This increas…